For laboratory research use only. Not for human or veterinary use.
  1. Home
  2. Catalog
  3. Metabolic & GLP research
  4. Tesamorelin

peptide

Tesamorelin

A stabilised GHRH(1-44) analogue with a trans-3-hexenoyl modification.

peptide

Tesamorelin

A stabilised GHRH(1-44) analogue with a trans-3-hexenoyl modification.

€ 90.00per vial, EUR

In stock

Presentation2 options
Choose amount and format
Lyophilised powder in a sealed glass vial
Storage: -20 °C for long-term storage; 2 to 8 °C for under three months; away from light
Tracked shipping EUR 9.95 per order. Benelux 1 to 2 business days, Germany and France 2 to 3, rest of Europe 3 to 5. Details
Batch certificate: not yet published online. Request one for this presentation.
Research use only. Not for human or veterinary use.

What it is

Tesamorelin is a synthetic 44-amino-acid analogue of growth-hormone-releasing hormone with an N-terminal trans-3-hexenoic acid group that protects it from enzymatic breakdown. It has been studied in clinical trials and is supplied here as a research reagent.

Where it has been studied

  • GHRH receptor pharmacology
  • Visceral adipose tissue models
  • IGF-1 axis studies

Selected literature

PubMed records selected for relevance to the compound. They describe published research, not outcomes or uses.

Specifications

CompoundTesamorelin
TypePeptide
Selected presentation5 mg · Lyophilised vial
FormLyophilised powder in a sealed glass vial
Fill volume and concentrationNot applicable (lyophilised)
LabelCELVIVE wordmark, compound name, amount, "Purity: >99%", "For research use only"
Storage-20 °C for long-term storage; 2 to 8 °C for under three months; away from light
Certificate of analysisNot yet published online. Request for a batch
Research areasMetabolic & GLP research, Growth hormone axis
All presentations5 mg lyophilised vial · € 90.00
10 mg lyophilised vial · € 45.00

Handling

  • Lyophilised peptides tolerate room temperature for several weeks in transit. Move to cold storage on receipt.
  • Reconstituted vials are typically used within three to four weeks at 2 to 8 °C; stability varies by compound.
  • Opened or unsealed vials cannot be returned. Transit damage must be documented within 24 hours.

Storage and stability FAQ